Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	0 mg prednisone	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 44 💬
2	5 mg prednisone	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 44 💬
3	5-aminosalicylic acid(5-asa) and/or prednisone	Aminosalicylic acid	[3] D00162, D00377, D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
4	Adalimumab, plus prednisone	Adalimumab	[2] D00473, D02597 💬	[2] NR3C1, TNF 💬	[66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	[1] 46 💬
5	Azathioprine/prednisone	Azathioprine	[3] D00238, D00473, D03033 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 85 💬
6	Chinese herb prescription granule plus prednisone	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
7	Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)	Acetate	[21] D00088, D00292, D00472, D00473, D00973, D00975, D00980, D00981, D00982, D01239, D01510, D01615, D01632, D01948, D01998, D02156, D02174, D02591, D02592, D03301, D07749 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 81 💬
8	Corticosteroids (prednisone or prednisolone)	Prednisolone	[9] D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 49 💬
9	Cyclophosphamide, azathioprine,prednisone,methylprednisolone	Azathioprine	[11] D00238, D00287, D00407, D00473, D00751, D00979, D03033, D05000, D05001, D05002, D07760 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[3] 42, 43, 45 💬
10	Cyclophosphamide-prednisone-azathioprine	Azathioprine	[5] D00238, D00287, D00473, D03033, D07760 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 49 💬
11	Glucocorticoid (prednisone or prednisolone)	Prednisolone	[9] D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 84 💬
12	Granulocyte-colony stimulating factor (g-csf) and prednisone	Filgrastim	[2] D00473, D03235 💬	[2] CSF3R, NR3C1 💬	[6] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer	[1] 13 💬
13	Hormone (prednisone)	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
14	Hydroxychloroquine + prednisone	Hydroxychloroquine	[2] D00473, D08050 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 84 💬
15	Ir prednisone	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 46 💬
16	Leflunomide 20 mg+prednisone 0.5mg/kg/d	Leflunomide	[2] D00473, D00749 💬	[2] DHODH, NR3C1 💬	[4] Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism	[1] 66 💬
17	Letrozole	Letrozole	[1] D00964 💬	[1] CYP19A1 💬	[3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis	[2] 81, 89 💬
18	Methylprednisolone (mp) or prednisone (pred)	Methylprednisolone	[7] D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
19	Mr prednisone	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 46 💬
20	Mycophenolate mofetil plus lower dose of prednisone	Mycophenolate mofetil	[5] D00473, D00752, D05094, D05095, D05096 💬	[3] IMPDH1, IMPDH2, NR3C1 💬	[4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism	[1] 66 💬
21	Oral prednisone	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 251 💬
22	Oral prednisone 5mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 49 💬
23	Other: prednisone	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 46 💬
24	Over encapsulated prednisone	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 41 💬
25	Prednisolone/prednisone	Prednisolone	[9] D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 49 💬
26	Prednisone	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[47]  2 ,  6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
27	Prednisone (and methylprednisolone)	Methylprednisolone	[7] D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 43 💬
28	Prednisone + inhibace/cozaar	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
29	Prednisone - azathioprine	Azathioprine	[3] D00238, D00473, D03033 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 11 💬
30	Prednisone 0,5 mg/kg orally on alternate days	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 222 💬
31	Prednisone 1 mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 46 💬
32	Prednisone 15 mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 46 💬
33	Prednisone 2 mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 46 💬
34	Prednisone 3 mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 46 💬
35	Prednisone 4 mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 46 💬
36	Prednisone 5 mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[2] 46, 66 💬
37	Prednisone 5 mg tablets	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 113 💬
38	Prednisone 7.5 mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 46 💬
39	Prednisone acetate	Acetate	[2] D00473, D08416 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[3] 40, 49, 224 💬
40	Prednisone acetate tablets	Acetate	[2] D00473, D08416 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 224 💬
41	Prednisone alone	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[2] 11, 66 💬
42	Prednisone and belimumab	Belimumab	[2] D00473, D03068 💬	[2] NR3C1, TNFSF13B 💬	[5] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis	[1] 300 💬
43	Prednisone and cyclophosphamide	Cyclophosphamide	[3] D00287, D00473, D07760 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
44	Prednisone and mycophenolate mofetil	Mycophenolate mofetil	[5] D00473, D00752, D05094, D05095, D05096 💬	[3] IMPDH1, IMPDH2, NR3C1 💬	[4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism	[1] 300 💬
45	Prednisone and ustekinumab treatment	Prednisone	[2] D00473, D09214 💬	[4] IL12A, IL12B, IL23A, NR3C1 💬	[27] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus	[1] 41 💬
46	Prednisone arrow 20mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
47	Prednisone arrow 5 mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
48	Prednisone capsules	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 41 💬
49	Prednisone discontinuation	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 49 💬
50	Prednisone in full dose	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
51	Prednisone or prednisolone	Prednisolone	[9] D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
52	Prednisone plus cyclophosphamide	Cyclophosphamide	[3] D00287, D00473, D07760 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 66 💬
53	Prednisone tablets usp, 1 mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[2] 41, 46 💬
54	Prednisone tablets usp, 2.5 mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 41 💬
55	Prednisone tablets usp, 5 mg	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[2] 41, 46 💬
56	Prednisone tablets, usp	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[3] 41, 43, 44 💬
57	Prednisone therapy and pharmacokinetic	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 41 💬
58	Prednisone treatment	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 41 💬
59	Prednisone, ciclosporin and mycophenolate mofetil	Cyclosporine	[6] D00184, D00473, D00752, D05094, D05095, D05096 💬	[8] IMPDH1, IMPDH2, NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	[36] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	[1] 222 💬
60	Prednisone, cyclophosphamide	Cyclophosphamide	[3] D00287, D00473, D07760 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 40 💬
61	Prednisone, fk506, mmf	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 222 💬
62	Prednisone, low dose rituximab	Prednisone	[2] D00473, D02994 💬	[2] MS4A1, NR3C1 💬	[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction	[1] 61 💬
63	Prednisone, methylprednisolone,cyclophosphamides	Methylprednisolone	[7] D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[3] 42, 43, 45 💬
64	Prednisone/prednisolone	Prednisolone	[9] D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 35 💬
65	Procedure: thymectomy plus prednisone	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 11 💬
66	Rayos (delayed-release prednisone)	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 46 💬
67	Sotatercept with prednisone boost	Prednisone	[2] D00473, D09670 💬	[2] ACVR2A, NR3C1 💬	[5] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway	[1] 284 💬
68	Tacrolimus combined with prednisone	Prednisone	[3] D00107, D00473, D08556 💬	[6] NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	[1] 222 💬
69	Thalidomide, cyclophosphamide and prednisone	Cyclophosphamide	[4] D00287, D00473, D00754, D07760 💬	[2] NR3C1, TNF 💬	[66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	[1] 331 💬
70	Treatment systemic therapy (prednisone)	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 162 💬
71	Treatment with systemic therapy (prednisone)	Prednisone	[1] D00473 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 162 💬
72	Ursodeoxycholic acid+low dose glucocorticoid(prednisone)	Prednisone	[2] D00473, D00734 💬	[2] NR1H4, NR3C1 💬	[2] Bile secretion, Neuroactive ligand-receptor interaction	[1] 93 💬

Back to top